PARKINSON THERAPY WITH L-DOPA

被引:0
|
作者
UMBACH, W
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:87 / &
相关论文
共 50 条
  • [21] L-DOPA THERAPY OF PARKINSONS DISEASE
    POECK, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1971, 96 (10) : 436 - &
  • [22] ASSESSING L-DOPA THERAPY FOR PARKINSONS
    KENT, S
    GERIATRICS, 1981, 36 (04) : 34 - +
  • [23] 7 YEARS OF L-DOPA THERAPY
    ROBERTSO.M
    NATURE, 1974, 250 (5462) : 104 - 104
  • [24] SECONDARY EFFECTS OF L-DOPA THERAPY
    GIRKE, W
    XENAKIS, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1975, 100 (42) : 2165 - 2169
  • [25] SUBSTITUTION THERAPY IN PARKINSONISM - L-DOPA, L-DOPA AND DECARBOXYLASE INHIBITOR OR 3-O-METHYL DOPA
    GAUTHIER, G
    AJURIAGU.JD
    GEISSBUHLER, F
    SIMONA, B
    CONSTANTINIDIS, J
    YANNIOTIS, G
    KRASSOIEVITCH, M
    EISENRING, JJ
    TISSOT, R
    PRESSE MEDICALE, 1971, 79 (03): : 91 - +
  • [26] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [27] Long Term Response to L-dopa in Parkinson Disease
    Gupta, H.
    Wachter, N.
    Lyons, K.
    Pahwa, R.
    MOVEMENT DISORDERS, 2018, 33 : S84 - S84
  • [28] The impact of L-dopa on axial impairments of the patients with Parkinson's disease: A motion analysis study during gait before and after L-dopa therapy
    Nikfekr, E
    Attfield, S
    Kerr, KM
    Ward, CD
    Playford, DE
    MOVEMENT DISORDERS, 2002, 17 : S89 - S90
  • [29] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
  • [30] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212